Editorial: Glucocorticoid and bone: Friend or foe
Main Authors: | Ulrike Baschant, Barbara Hauser, Elizabeth Martha Winter |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.995124/full |
Similar Items
-
Corrigendum: When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
by: Kaleen N. Hayes, et al.
Published: (2022-03-01) -
Endogenous Glucocorticoid Metabolism in Bone: Friend or Foe
by: Claire S. Martin, et al.
Published: (2021-08-01) -
Ukrainian guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis
by: N.V. Grygorieva, et al.
Published: (2024-09-01) -
The molecular etiology and treatment of glucocorticoid-induced osteoporosis
by: Cheng-Huan Peng, et al.
Published: (2021-01-01) -
Regulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans
by: Sylvia Thiele, et al.
Published: (2019-07-01)